“…NF-κB signaling is a hallmark that promotes lymphoma growth and survival by activating anti-apoptotic and pro-proliferative gene programs in many lymphoid malignancies including HL, diffuse large B-cell lymphoma (DLBCL), mucosa-associated lymphoid tissue (MALT) lymphoma, primary effusion lymphoma and adult T-cell lymphoma/leukemia (ATLL) [ 7 , 8 ]. Moreover, the increase in several adipose tissue-released cytokines such as interleukin (IL)-6, IL-8, IL-10, monocyte chemoattractant protein (MCP)-1 and IL-1 have been shown in several types of lymphoma [ 9 ].…”